On April 27, 2010 the agreement on sale of Sanitas, AB subsidiary HBM Pharma s.r.o. was signed between Sanitas, AB and Latvian company SIA Liplats 2000. The parties agreed that only the manufacturing site of HBM Pharma s.r.o. located in Martin, Slovakia will be sold to Latvian company. Marketing, sales and regulatory divisions located in Bratislava and Prague will be separated from HBM Pharma s.r.o. and transferred to Sanitas group together with employees and assets of the said divisions.
The purchase price of HBM Pharma s.r.o. will be finalised at closing and will depend on company’s liabilities towards credit institutions and working capital. The transaction is planned to be finished in two months.